Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis
- 1 November 2006
- journal article
- research article
- Published by Elsevier in The Lancet Oncology
- Vol. 7 (11) , 910-918
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Established breast cancer risk factors by clinically important tumour characteristicsBritish Journal of Cancer, 2006
- Relationship between Established Breast Cancer Risk Factors and Risk of Seven Different Histologic Types of Invasive Breast CancerCancer Epidemiology, Biomarkers & Prevention, 2006
- Current evidence about the effect of hormone replacement therapy on the incidence of major conditions in postmenopausal womenBJOG: An International Journal of Obstetrics & Gynaecology, 2005
- Hormone replacement therapy in relation to breast carcinoma incidence rate ratiosCancer, 2004
- Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in EuropeInternational Journal of Cancer, 2004
- Breast cancer and hormone-replacement therapy in the Million Women StudyThe Lancet, 2003
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Increased incidence of small and well-differentiated breast tumours in post-menopausal women following hormone-replacement therapyInternational Journal of Cancer, 2001
- Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancerThe Lancet, 1997
- The Risk of Breast Cancer after Estrogen and Estrogen–Progestin ReplacementNew England Journal of Medicine, 1989